Higgins John L reported option exercise involving 15,940 derivative units of BIO-TECHNE Corp at $0.00 for $0 on Sep 28, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Director
DIR
Filed Sep 30, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
15,940Stock Options (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
0Direct
Trade date
Sep 28, 2026Option exercise
Filed
Sep 30, 2026, 4:13 PM ET2-day reporting delay
Accession
0000914190-26-000142Code M · Transaction 231664
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 28, 2026Option exercise15,940$0.00$0Trade 231662
Sep 28, 2026Tax withholding5,562$72.51−$403,300.62Trade 231663
3 transaction rows in this filing. Joint filers share the same rows.

TECH price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
TECH · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −0.2%1w ago 0%1d ago +0.2%
Returns since7d +0.1%30d +0.3%90d180d1y

Footnotes in full

F1: The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.